MannKind to Present at Upcoming Conferences
Get Alerts MNKD Hot Sheet
Join SI Premium – FREE
VALENCIA, Calif., May 27, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes, announced today that it will present at upcoming conferences.
- Jefferies 2015 Global Healthcare Conference on Wednesday, June 3, 2015 at 2:00 pm (ET) in New York, New York.
- Goldman Sachs 36th Annual Global Healthcare Conference on Wednesday, June 10, 2015 at 8:40 am (PT) at the Terranea Resort in Rancho Palos Verdes, California.
- JMP Securities Life Sciences Conference on Wednesday, June 24, 2015 at 9:30 am (ET) at the St. Regis Hotel in New York, New York.
Interested parties can access a link to the live webcast of the presentations from the News & Events section of the Company's website at http://www.mannkindcorp.com.
About MannKind Corporation
MannKind Corporation (Nasdaq: MNKD) focuses on the discovery and development of therapeutic products for patients with diseases such as diabetes. MannKind maintains a website at http://www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.
CONTACT: Company Contact:
Matthew J. Pfeffer
Chief Financial Officer
(661) 775-5300
[email protected]
Source: MannKind Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Enanta Pharmaceuticals sets up $75M at-the-market stock offering
- Critical Metals Corp. amends European Lithium deal mechanics
- Haverty Furniture expands credit facility to $100M, extends to 2031
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Goldman Sachs, Jefferies & Co, JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share